{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:26:25Z","timestamp":1758893185157,"version":"3.37.3"},"reference-count":46,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1124\/dmd.106.010827","type":"journal-article","created":{"date-parts":[[2006,9,20]],"date-time":"2006-09-20T02:26:31Z","timestamp":1158719191000},"page":"1995-2002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Investigation of Structure and Function of a Catalytically Efficient Variant of the Human Flavin-Containing Monooxygenase Form 3"],"prefix":"10.1016","volume":"34","author":[{"given":"T\u00edmea","family":"Borb\u00e1s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matt A.","family":"Cerny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n","family":"Lik\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Cashman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.106.010827_bib1","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/(SICI)1098-1004(1999)13:5<376::AID-HUMU5>3.0.CO;2-A","article-title":"Two mutations of the FMO3 gene in a proband with trimethylaminuria.","volume":"13","author":"Akerman","year":"1999","journal-title":"Hum Mutat"},{"key":"10.1124\/dmd.106.010827_bib2","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.bbrc.2005.09.081","article-title":"Dynamics involved in catalysis by single-component and two-component flavin-dependent aromatic hydroxylases.","volume":"338","author":"Ballou","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.106.010827_bib3","series-title":"Microsomes, Drug Oxidation and Chemical Carcinogenesis","first-page":"209","article-title":"A kinetic investigation of liver microsomal mixed function amine oxidase","author":"Beaty","year":"1980"},{"key":"10.1124\/dmd.106.010827_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank.","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/dmd.106.010827_bib5","first-page":"1001","article-title":"Characterization of two human flavin-containing monooxygenase (form 3) enzymes expressed in Escherichia coli as maltose binding protein fusions.","volume":"25","author":"Brunelle","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.106.010827_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1021\/tx00044a001","article-title":"Structural and catalytic properties of the mammalian flavin-containing monooxygenase.","volume":"8","author":"Cashman","year":"1995","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.106.010827_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/14622416.3.3.325","article-title":"Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism.","volume":"3","author":"Cashman","year":"2002","journal-title":"Pharmacogenomics"},{"key":"10.1124\/dmd.106.010827_bib8","series-title":"Enzyme Systems that Metabolize Drugs and Other Xenobiotics","first-page":"67","article-title":"Flavin monooxygenases","author":"Cashman","year":"2002"},{"key":"10.1124\/dmd.106.010827_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/1389200033489505","article-title":"Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria.","volume":"4","author":"Cashman","year":"2003","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.106.010827_bib10","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1124\/dmd.30.10.1043","article-title":"Interindividual differences of human flavin-containing monooxygenase 3: genetic polymorphisms and functional variation.","volume":"30","author":"Cashman","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.106.010827_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev.pharmtox.46.120604.141043","article-title":"Human flavin-containing monooxygenases.","volume":"46","author":"Cashman","year":"2006","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.106.010827_bib12","first-page":"1629","article-title":"Population distribution of human flavin-containing monooxygenase form 3: gene polymorphisms.","volume":"29","author":"Cashman","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.106.010827_bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0003-9861(84)90600-3","article-title":"Spectrophotometric assay of the flavin-containing monooxygenase and changes in its activity in female mouse liver with nutritional and diurnal conditions.","volume":"233","author":"Dixit","year":"1984","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.106.010827_bib14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng1297-491","article-title":"Missense mutation in flavin-containing monooxygenase 3 gene, underlies fish-odour syndrome.","volume":"17","author":"Dolphin","year":"1997","journal-title":"Nat Genet"},{"key":"10.1124\/dmd.106.010827_bib15","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/00008571-200012000-00005","article-title":"Compound heterozygosity for missense mutations in the flavin-containing monooxygenase 3 (FMO3) gene in patients with fish-odour syndrome.","volume":"20","author":"Dolphin","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.106.010827_bib16","doi-asserted-by":"crossref","first-page":"9832","DOI":"10.1073\/pnas.0602398103","article-title":"Mechanism of action of a flavin-containing monooxygenase.","volume":"103","author":"Eswaramoorthy","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.106.010827_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1124\/dmd.31.2.187","article-title":"Identification of novel variants of the flavin-containing monooxygenase gene family in African Americans.","volume":"31","author":"Furnes","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.106.010827_bib18","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/elps.1150181505","article-title":"SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling.","volume":"18","author":"Guex","year":"1997","journal-title":"Electrophoresis"},{"key":"10.1124\/dmd.106.010827_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0006-2952(00)00301-4","article-title":"Stereoselective sulfoxidation of sulindac sulfide by flavin-containing monooxygenases. Comparison of human liver and kidney microsomes and mammalian enzymes.","volume":"60","author":"Hamman","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.106.010827_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00008571-200402000-00006","article-title":"Organization and evolution of the flavin-containing monooxygenase genes of human and mouse; identification of novel gene pseudogene clusters.","volume":"14","author":"Hernandez","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.106.010827_bib21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1124\/mol.62.2.320","article-title":"Alternative processing of the human FMO6 gene renders transcripts incapable of encoding a functional flavin-containing monooxygenase.","volume":"62","author":"Hines","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.106.010827_bib22","doi-asserted-by":"crossref","first-page":"8357","DOI":"10.1158\/1078-0432.CCR-04-1073","article-title":"Genetic polymorphisms of human flavin-containing monooxygenase 3 in sulindac-mediated primary chemoprevention of familial adenomatous polyposis.","volume":"10","author":"Hisamuddin","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1124\/dmd.106.010827_bib23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00008571-200002000-00009","article-title":"Phenotypes of flavin-containing monooxygenase activity determined by ranitidine N-oxidation are positively correlated with genotypes of linked FM03 gene mutations in a Korean population.","volume":"10","author":"Kang","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.106.010827_bib24","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2217\/14622416.6.8.807","article-title":"Flavin-containing monooxygenase genetic polymorphism: impact on chemical metabolism and drug development.","volume":"8","author":"Koukouritaki","year":"2005","journal-title":"Pharmacogenomics"},{"key":"10.1124\/dmd.106.010827_bib25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1124\/mol.105.012062","article-title":"Discovery of novel flavin-containing monooxygenase 3 (FMO3) single nucleotide polymorphisms and functional analysis of upstream haplotype variants.","volume":"68","author":"Koukouritaki","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.106.010827_bib26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.pharmthera.2005.01.001","article-title":"Mammalian flavin-containing monooxygenases: structure\/function, genetic polymorphisms, and role in drug metabolism.","volume":"106","author":"Krueger","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.106.010827_bib27","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4.","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature (Lond)"},{"key":"10.1124\/dmd.106.010827_bib28","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1124\/mol.65.6.1517","article-title":"Alternative processing events in human FMO genes.","volume":"65","author":"Lattard","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.106.010827_bib29","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1124\/dmd.31.7.854","article-title":"Two new polymorphisms of the FMO3 gene in Caucasian and African-American populations: comparative genetic and functional studies.","volume":"31","author":"Lattard","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.106.010827_bib30","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/abbi.1994.1035","article-title":"A nomenclature for the mammalian flavin-containing monooxygenase gene family based on amino acid sequence identity.","volume":"308","author":"Lawton","year":"1994","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.106.010827_bib31","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1073\/pnas.89.5.1685","article-title":"Molecular cloning of flavin-containing monooxygenase (form II) cDNA from adult human liver.","volume":"89","author":"Lomri","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.106.010827_bib32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1021\/tx00034a006","article-title":"Expression in Escherichia coli of the flavin-containing monooxygenase D (form II) from adult human liver: determination of a distinct tertiary amine substrate specificity.","volume":"6","author":"Lomri","year":"1993","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.106.010827_bib33","doi-asserted-by":"crossref","first-page":"13157","DOI":"10.1073\/pnas.0404538101","article-title":"Crystal structure of a Baeyer-Villiger monooxygenase.","volume":"101","author":"Malito","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.106.010827_bib34","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00008571-200411000-00009","article-title":"Benzydamine metabolism in vivo is impaired in patients with deficiency of flavin-containing monooxygenase 3.","volume":"14","author":"Mayatepek","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.106.010827_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00008571-199702000-00006","article-title":"Studies on the discontinuous N-oxidation of trimethylamine among Jordanian, Ecuadorian and New Guinean populations.","volume":"7","author":"Mitchell","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.106.010827_bib36","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/pro.5560030916","article-title":"Anatomy of an engineered NAD-binding site.","volume":"9","author":"Mittl","year":"1994","journal-title":"Protein Sci"},{"key":"10.1124\/dmd.106.010827_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00008571-200201000-00011","article-title":"Ethnic differences in allelic frequency of two flavin-containing monooxygenase 3 (FMO3) polymorphisms: linkage and effects on in vivo and in vitro FMO activities.","volume":"12","author":"Park","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.106.010827_bib38","first-page":"658","article-title":"Protein modeling by email.","volume":"13","author":"Peitsch","year":"1995","journal-title":"Bio\/Technology"},{"key":"10.1124\/dmd.106.010827_bib39","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.1016\/S0021-9258(18)50388-4","article-title":"The liver microsomal FAD-containing monooxygenase: spectral characterization and kinetic studies.","volume":"254","author":"Poulsen","year":"1979","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.106.010827_bib40","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1093\/nar\/gkg520","article-title":"SWISS-MODEL: an automated protein homology-modeling server.","volume":"31","author":"Schwede","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/dmd.106.010827_bib41","first-page":"1325","article-title":"Structure of NADH peroxidase from Streptococcus faecalis 10C1 refined at 2.16 angstroms resolution.","volume":"221","author":"Stehle","year":"1991","journal-title":"J Mol Biol"},{"key":"10.1124\/dmd.106.010827_bib42","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/hmg\/7.5.839","article-title":"Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication.","volume":"7","author":"Treacy","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1124\/dmd.106.010827_bib43","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1021\/bi972622b","article-title":"Identification of amino acid residues associated with modulation of flavin-containing monooxygenase (FMO) activity by imipramine: structure\/function studies with FMO1 from pig and rabbit.","volume":"37","author":"Wyatt","year":"1998","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.106.010827_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1124\/dmd.105.006171","article-title":"Quantitative analysis of FMO gene mRNA levels in human tissues.","volume":"34","author":"Zhang","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.106.010827_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/03602538809049617","article-title":"Flavin-containing monooxygenases: catalytic mechanism and substrate specificities.","volume":"19","author":"Ziegler","year":"1988","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.106.010827_bib46","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1081\/DMR-120005650","article-title":"An overview of the mechanism, substrate specificities, and structure of FMOs.","volume":"34","author":"Ziegler","year":"2002","journal-title":"Drug Metab Rev"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624036729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624036729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.106.010827","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:11:20Z","timestamp":1739902280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624036729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0090955624036729"],"URL":"https:\/\/doi.org\/10.1124\/dmd.106.010827","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2006,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of Structure and Function of a Catalytically Efficient Variant of the Human Flavin-Containing Monooxygenase Form 3","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.106.010827","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}